{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:30:28Z","timestamp":1790400628735,"version":"4.1.0"},"reference-count":47,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Rare Disorders Reference Centre CRESCENDO"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Silver-Russell syndrome (SRS) is an imprinting disorder characterized by severe intrauterine and postnatal growth retardation, feeding difficulties, and risk of hypoglycemia. Recombinant growth hormone (rGH) therapy has shown its positive effect on adult height in SRS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to assess the short-term effects of rGH therapy on the growth and nutritional status of these children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective monocentric data of growth and nutritional characteristics of 77 prepubertal children with molecularly proven SRS during the first 2 years of rGH therapy were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age at the initiation of rGH therapy was 3.7 (1.4-10.3) years. The mean height gain was 0.8 standard deviation score (SDS) after 1 year of treatment and 1.3 SDS after 2 years. The ideal weight for height (WfH), reflecting the nutritional status, increased from a mean of 81% at rGH initiation, to 84% after 1 year of treatment (P &amp;lt; .001) and 86% after 2 years (P &amp;lt; .001). The proportion of SRS children below a WfH of 75% decreased from 22.1% at rGH therapy initiation to 7.8% after 2 years of treatment. Starting rGH therapy before the age of 4 years was associated with a greater increase in height after 2 years, 1.5 vs 1.1 SDS, P = .012.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In prepubertal SRS children, the first 2 years of standard-dose rGH therapy significantly enhance both height and nutritional status. Early initiation of treatment, before the age of 4 years, further optimizes height gain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf452","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T07:03:34Z","timestamp":1755587014000},"page":"e900-e907","source":"Crossref","is-referenced-by-count":3,"title":["Early Growth Hormone Treatment Enhances Growth and Nutritional Status in Silver-Russell Syndrome"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5360-8616","authenticated-orcid":false,"given":"Elo\u00efse","family":"Giabicani","sequence":"first","affiliation":[{"name":"INSERM, Sorbonne Universit\u00e9, Centre de Recherche Saint Antoine, APHP, H\u00f4pital Armand Trousseau, Explorations Fonctionnelles Endocriniennes , Paris F-75012 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00eblle","family":"Billette de Villemeur","sequence":"additional","affiliation":[{"name":"APHP, Sorbonne Universit\u00e9, H\u00f4pital Armand Trousseau, Explorations Fonctionnelles Endocriniennes , Paris F-75012 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lodie","family":"Acher","sequence":"additional","affiliation":[{"name":"APHP, Sorbonne Universit\u00e9, H\u00f4pital Armand Trousseau, Explorations Fonctionnelles Endocriniennes , Paris F-75012 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Cochet","sequence":"additional","affiliation":[{"name":"INSERM, Sorbonne Universit\u00e9, Centre de Recherche Saint Antoine , Paris F-75012 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3480-0246","authenticated-orcid":false,"given":"Am\u00e9lie","family":"Perri\u00e8re","sequence":"additional","affiliation":[{"name":"APHP, Sorbonne Universit\u00e9, H\u00f4pital Armand Trousseau, Explorations Fonctionnelles Endocriniennes , Paris F-75012 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2614-7556","authenticated-orcid":false,"given":"B\u00e9atrice","family":"Dubern","sequence":"additional","affiliation":[{"name":"INSERM U1269, Sorbonne Universit\u00e9, Nutriomics, APHP, H\u00f4pital Armand Trousseau, Service de Nutrition et de Gastroent\u00e9rologie P\u00e9diatriques , Paris F-75012 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-3389","authenticated-orcid":false,"given":"Ir\u00e8ne","family":"Netchine","sequence":"additional","affiliation":[{"name":"INSERM, Sorbonne Universit\u00e9, Centre de Recherche Saint Antoine, APHP, H\u00f4pital Armand Trousseau, Explorations Fonctionnelles Endocriniennes , Paris F-75012 ,","place":["France"]},{"name":"INSERM, Sorbonne Universit\u00e9, Centre de Recherche Saint Antoine, APHP, H\u00f4pital Armand Trousseau, Endocrinologie mol\u00e9culaire et Pathologies d'empreinte, Paris F-75012 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"4","key":"2026021918523052300_dgaf452-B1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1542\/peds.12.4.368","article-title":"Syndrome of congenital hemihypertrophy, shortness of stature, and elevated urinary gonadotropins","volume":"12","author":"Silver","year":"1953","journal-title":"Pediatrics"},{"issue":"12","key":"2026021918523052300_dgaf452-B2","first-page":"1040","article-title":"A syndrome of intra-uterine dwarfism recognizable at birth with cranio-facial dysostosis, disproportionately short arms, and other anomalies (5 examples)","volume":"47","author":"Russell","year":"1954","journal-title":"Proc R Soc Med"},{"issue":"7","key":"2026021918523052300_dgaf452-B3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jmedgenet-2014-102979","article-title":"A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome","volume":"52","author":"Azzi","year":"2015","journal-title":"J Med Genet"},{"issue":"2","key":"2026021918523052300_dgaf452-B4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrendo.2016.138","article-title":"Diagnosis and management of Silver-Russell syndrome: first international consensus statement","volume":"13","author":"Wakeling","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"2026021918523052300_dgaf452-B5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng1629","article-title":"Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome","volume":"37","author":"Gicquel","year":"2005","journal-title":"Nat Genet"},{"issue":"4","key":"2026021918523052300_dgaf452-B6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/hmg\/4.4.583","article-title":"Uniparental disomy 7 in Silver-Russell syndrome and primordial growth retardation","volume":"4","author":"Kotzot","year":"1995","journal-title":"Hum Mol Genet"},{"issue":"8","key":"2026021918523052300_dgaf452-B7","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1210\/jc.2007-0354","article-title":"11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations","volume":"92","author":"Netchine","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026021918523052300_dgaf452-B8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/endrev\/bnad002","article-title":"International consensus guideline on small for gestational age: etiology and management from infancy to early adulthood","volume":"44","author":"Hokken-Koelega","year":"2023","journal-title":"Endocr Rev"},{"issue":"12","key":"2026021918523052300_dgaf452-B9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/BF01958638","article-title":"Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients","volume":"154","author":"Wollmann","year":"1995","journal-title":"Eur J Pediatr"},{"issue":"4","key":"2026021918523052300_dgaf452-B10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000289570","article-title":"Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS","volume":"74","author":"Ranke","year":"2010","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2026021918523052300_dgaf452-B11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000023196","article-title":"Growth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation\/Russell-Silver syndrome","volume":"50","author":"Azcona","year":"1998","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2026021918523052300_dgaf452-B12","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1210\/jc.2015-4273","article-title":"Long-term results of GH treatment in Silver-Russell syndrome (SRS): do they benefit the same as non-SRS short-SGA?","volume":"101","author":"Smeets","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026021918523052300_dgaf452-B13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000354658","article-title":"Adult height and epigenotype in children with Silver-Russell syndrome treated with GH","volume":"80","author":"Binder","year":"2013","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"2026021918523052300_dgaf452-B14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/archdischild-2013-305864","article-title":"Prevalence and management of gastrointestinal manifestations in Silver\u2013Russell syndrome","volume":"100","author":"Marsaud","year":"2015","journal-title":"Arch Dis Child"},{"issue":"11","key":"2026021918523052300_dgaf452-B15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/jmg.2010.079111","article-title":"Epigenotype-phenotype correlations in Silver-Russell syndrome","volume":"47","author":"Wakeling","year":"2010","journal-title":"J Med Genet"},{"issue":"7","key":"2026021918523052300_dgaf452-B16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1515\/JPEM.2005.18.7.663","article-title":"Hypoglycaemia and Russell-Silver syndrome","volume":"18","author":"Azcona","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"2026021918523052300_dgaf452-B17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/apa.17474","article-title":"Percutaneous endoscopic gastrostomy helped to normalise feeding problems and gastrointestinal symptoms in Silver-Russell syndrome","volume":"114","author":"Muz","year":"2025","journal-title":"Acta Paediatrica"},{"issue":"2","key":"2026021918523052300_dgaf452-B18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/MPG.0000000000001708","article-title":"Effect of cyproheptadine on weight and growth velocity in children with Silver-Russell syndrome","volume":"66","author":"Lemoine","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"2026021918523052300_dgaf452-B19","first-page":"2225","article-title":"Clinical manifestations and metabolic outcomes of seven adults with Silver-Russell syndrome","volume":"103","author":"Patti","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026021918523052300_dgaf452-B20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrendo.2016.127","article-title":"Long-term metabolic risk among children born premature or small for gestational age","volume":"13","author":"Mericq","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"2026021918523052300_dgaf452-B21","doi-asserted-by":"crossref","first-page":"e2001","DOI":"10.1210\/clinem\/dgae074","article-title":"Body composition and metabolism in adults with molecularly-confirmed Silver-Russell syndrome","volume":"109","author":"Lokulo-Sodipe","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026021918523052300_dgaf452-B22","first-page":"983","article-title":"Metabolic health and long-term safety of growth hormone treatment in Silver-Russell syndrome","volume":"102","author":"Smeets","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026021918523052300_dgaf452-B23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/cen.14715","article-title":"Height and body mass index in molecularly confirmed Silver-Russell syndrome and the long-term effects of growth hormone treatment","volume":"97","author":"Lokulo-Sodipe","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5826","key":"2026021918523052300_dgaf452-B24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/bmj.3.5826.566","article-title":"Classification and definition of protein-calorie malnutrition","volume":"3","author":"Waterlow","year":"1972","journal-title":"Br Med J"},{"issue":"5","key":"2026021918523052300_dgaf452-B25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/sim.8007","article-title":"The use of weight adjusted for height rather than body mass index to assess growth trajectory: results from a population-based cohort","volume":"38","author":"Ara\u00fajo","year":"2019","journal-title":"Stat Med"},{"issue":"6","key":"2026021918523052300_dgaf452-B26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1651-2227.2000.tb00357.x","article-title":"Effect of growth hormone therapy on feeding problems and food intake in children with growth disorders","volume":"89","author":"Blissett","year":"2000","journal-title":"Acta Paediatr"},{"issue":"12","key":"2026021918523052300_dgaf452-B27","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1210\/jc.2003-030512","article-title":"Puberty in growth hormone-treated children born small for gestational age (SGA)","volume":"88","author":"Boonstra","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026021918523052300_dgaf452-B28","doi-asserted-by":"crossref","first-page":"975511","DOI":"10.3389\/fendo.2022.975511","article-title":"Pubertal timing in children with Silver Russell syndrome compared to those born small for gestational age","volume":"13","author":"Patti","year":"2022","journal-title":"Front Endocrinol"},{"issue":"2","key":"2026021918523052300_dgaf452-B29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/humu.21403","article-title":"Allele-specific methylated multiplex real-time quantitative PCR (ASMM RTQ-PCR), a powerful method for diagnosing loss of imprinting of the 11p15 region in Russell Silver and Beckwith Wiedemann syndromes","volume":"32","author":"Azzi","year":"2011","journal-title":"Hum Mutat"},{"issue":"6","key":"2026021918523052300_dgaf452-B30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-3476(69)80224-6","article-title":"Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation","volume":"74","author":"Usher","year":"1969","journal-title":"J Pediatr"},{"key":"2026021918523052300_dgaf452-B31","first-page":"111","article-title":"Child growth from 0 to 7 years of age","volume":"21","author":"Sempe","year":"1964","journal-title":"Arch Fr Pediatr"},{"issue":"1","key":"2026021918523052300_dgaf452-B32","first-page":"13","article-title":"Body Mass Index variations: centiles from birth to 87 years","volume":"45","author":"Rolland-Cachera","year":"1991","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"2026021918523052300_dgaf452-B33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000071871","article-title":"Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study","volume":"60","author":"Brabant","year":"2003","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2026021918523052300_dgaf452-B34","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026021918523052300_dgaf452-B35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5603\/EP.a2023.0042","article-title":"The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome","volume":"74","author":"\u015awi\u0105der-Le\u015bniak","year":"2023","journal-title":"Endokrynol Pol"},{"issue":"8","key":"2026021918523052300_dgaf452-B36","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2007-0078","article-title":"Improvement in growth after two years of growth hormone therapy in very young children born small for gestational age and without spontaneous catch-up growth: results of a multicenter, controlled, randomized, open clinical trial","volume":"92","author":"Argente","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026021918523052300_dgaf452-B37","doi-asserted-by":"crossref","first-page":"e1705","DOI":"10.1210\/clinem\/dgz165","article-title":"A comprehensive cohort analysis comparing growth and GH therapy response in IGF1R mutation carriers and SGA children","volume":"105","author":"G\u00f6pel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026021918523052300_dgaf452-B38","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/BF02282833","article-title":"Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand growth database (OZGROW)","volume":"155","author":"Rakover","year":"1996","journal-title":"Eur J Pediatr"},{"issue":"11","key":"2026021918523052300_dgaf452-B39","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/jc.2012-1987","article-title":"Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial","volume":"97","author":"Lem","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026021918523052300_dgaf452-B40","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1210\/jc.2007-1897","article-title":"The endocrine phenotype in Silver-Russell syndrome is defined by the underlying epigenetic alteration","volume":"93","author":"Binder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026021918523052300_dgaf452-B41","doi-asserted-by":"crossref","first-page":"e1291","DOI":"10.1210\/clinem\/dgz118","article-title":"Increases in bioactive IGF do not parallel increases in total IGF-I during growth hormone treatment of children born SGA","volume":"105","author":"Wegmann","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026021918523052300_dgaf452-B42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000090376","article-title":"Food intake of children with short stature born small for gestational age before and during a randomized GH trial","volume":"65","author":"Boonstra","year":"2006","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2026021918523052300_dgaf452-B43","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"Growth hormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026021918523052300_dgaf452-B44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement","volume":"14","author":"Mantovani","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2026021918523052300_dgaf452-B45","doi-asserted-by":"crossref","first-page":"1379897","DOI":"10.3389\/fpubh.2024.1379897","article-title":"Age- and height-dependent bias of underweight and overweight assessment standards for children and adolescents","volume":"12","author":"Isoyama","year":"2024","journal-title":"Front Public Health"},{"issue":"5","key":"2026021918523052300_dgaf452-B46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00125-005-1724-4","article-title":"Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth","volume":"48","author":"Jaquet","year":"2005","journal-title":"Diabetologia"},{"issue":"3","key":"2026021918523052300_dgaf452-B47","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/pubmed\/fdv067","article-title":"Body mass index relates weight to height differently in women and older adults: serial cross-sectional surveys in England (1992\u20132011)","volume":"38","author":"Sperrin","year":"2016","journal-title":"J. Public Health Oxf Engl"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf452\/64081223\/dgaf452.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/e900\/64081223\/dgaf452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/e900\/64081223\/dgaf452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:52:47Z","timestamp":1771545167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/3\/e900\/8237732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,19]]},"published-print":{"date-parts":[[2026,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf452","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,8,19]]}}}